Yale’s Post ASH Review: Highlights from the 2025 American Society of Hematology Annual Meeting

Friday, March 13, 2026, 7:30 AM - 3:00 PM, Anthony's Ocean View, 450 Lighthouse Road, New Haven, CT


This meeting will recap the major takeaways from ASH through a program designed for hematologists involved in the treatment of patients with blood cancer.

1. Describe the current treatment options and updates in various lymphoma, multiple myeloma, leukemia, and myeloid malignancies.
2. Discuss the development and outcomes of clinical research trials, cellular therapies, and transplant options for hematological malignancies and assess their relevance to patient care
3. Assess the emerging role of immunotherapy, targeted therapies, cellular therapies and antibodies in hematological malignancies
4. Review updates in classical hematology, including bleeding disorders and thrombosis

Registration is complimentary; however, we require you to register to account for seating and meals.

If you have any questions, please contact the Center for Continuing Medical Education at [email protected].

 

 

 

Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement
Yale School of Medicine approves this live activity for 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC POINTS ~ Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 6.25 Medical Knowledge Only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Part II program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Financial Statement
The Yale School of Medicine and Yale Cancer Center are grateful to their supporters. They are acknowledged in all conference materials. 

This symposium is being held at Anthony's Ocean View, located at 450 Lighthouse Rd, New Haven, CT 06512. Free on-site parking is available. 

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.